Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
A Memorandum of Understanding on the promotion and financing of 700 JLGs was signed on Thursday and exchanged between NABARD, J&K Regional Office and Jammu & Kashmir Grameen Bank in the conference hall of NABARD, J&K Regional Office.
EXAMIANS